Akbari A et al (2014) Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma. DARU J Pharm Sci 22:1–7

Article  Google Scholar 

Akbari A et al (2016) Modulation of transforming growth factor-β signaling transducers in colon adenocarcinoma cells induced by staphylococcal enterotoxin B. Mol Med Rep 13(1):909–914

Article  CAS  PubMed  Google Scholar 

Ali HM, Ellakwa DE, Elaraby NM, Zaher AM, Amr KS (2023) Study the association of microRNA polymorphisms (miR-146a, miR-4513) with the risk of coronary heart diseases in Egyptian population. J Biochem Mol Toxicol 37(3):e23284

Article  CAS  PubMed  Google Scholar 

Amirkhah R et al (2015) MicroRNA–mRNA interactions in colorectal cancerand their role in tumor progression. Genes Chromosomes Cancer 54(3):129–141

Article  CAS  PubMed  Google Scholar 

An X, Sarmiento C, Tan T, Zhu H (2017) Regulation of multidrug resistance by microRNAs in anti-cancer therapy. Acta Pharm Sin B 7(1):38–51

Article  PubMed  Google Scholar 

Araghi M et al (2019) Changes in colorectal cancerincidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol 4(7):511–518

Article  PubMed  Google Scholar 

Bach DH, Hong JY, Park HJ, Lee SK (2017) The role of exosomes and miRNAs in drug-resistance of cancer cells. Int J Cancer 141(2):220–230

Article  CAS  PubMed  Google Scholar 

Balacescu O, Sur D, Cainap C, Visan S, Cruceriu D, Manzat-Saplacan R, Muresan MS, Balacescu L, Lisencu C, Irimie A (2018) The impact of miRNA in colorectal cancer progression and its liver metastases. Int J Mol Sci 19(12):3711

Article  PubMed  PubMed Central  Google Scholar 

Bartel DP (2018) Metazoan micrornas. Cell 173(1):20–51

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benedix F et al (2010) Comparison of 17,641 patients with right-and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53(1):57–64

Article  PubMed  Google Scholar 

Bjørnetrø T et al (2019) An experimental strategy unveiling exosomal microRNAs 486–5p, 181a–5p and 30d–5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer. J Extracell Vesicles 8(1):1567219

Article  PubMed  PubMed Central  Google Scholar 

Brody H (2015) Colorectal cancer. Nature 521:S1. https://doi.org/10.1038/521S1a

Article  CAS  PubMed  Google Scholar 

Brown LJ, Roeger SL, Reed RL (2019) Patient perspectives on colorectal cancerscreening and the role of general practice. BMC Fam Pract 20(1):1–9

Article  CAS  Google Scholar 

Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866

Article  CAS  PubMed  Google Scholar 

Che J et al (2019) miR-20a inhibits hypoxia-induced autophagy by targeting ATG5/FIP200 in colorectal cancer. Mol Carcinog 58(7):1234–1247

Article  CAS  PubMed  Google Scholar 

Chen L-L, Yang L (2015) Regulation of circRNA biogenesis. RNA Biol 12(4):381–388

Article  PubMed  PubMed Central  Google Scholar 

Chen B et al (2019) Emerging microRNA biomarkers for colorectal cancerdiagnosis and prognosis. R Soc Open Biol 9(1):180212

Article  CAS  Google Scholar 

Chen LY et al (2020) The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancerby miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation. Mol Cancer 19(1):164

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng C-C et al (2020) STAT3 mediated miR-30a-5p inhibition enhances proliferation and inhibits apoptosis in colorectal cancer cells. Int J Mol Sci 21(19):7315

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho WC (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42(8):1273–1281

Article  CAS  PubMed  Google Scholar 

Chu CA et al (2019) MiR-338-5p promotes metastasis of colorectal cancerby inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway. EBioMedicine 43:270–281

Article  PubMed  PubMed Central  Google Scholar 

Dai X, Xie Y, Dong M (2022) Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis. Cancer Biol Ther 23(1):76–88

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desmond BJ, Dennett ER, Danielson KM (2019) Circulating extracellular vesicle microRNA as diagnostic biomarkers in early colorectal cancer—a review. Cancers 12(1):52

Article  PubMed  PubMed Central  Google Scholar 

Ding J et al (2018) MiR-223 promotes the doxorubicin resistance of colorectal cancercells via regulating epithelial–mesenchymal transition by targeting FBXW7. Acta Biochim Biophys Sin 50(6):597–604

Article  CAS  PubMed  Google Scholar 

Doghish AS et al (2021) Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in adult Egyptian male patients with metabolic syndrome. Can J Diabetes 45(7):614–618

Article  PubMed  Google Scholar 

Doghish AS et al (2022) A review of the biological role of miRNAs in prostate cancer suppression and progression. Int J Biol Macromol 197:141–156

Article  CAS  PubMed  Google Scholar 

Dou R et al (2021) EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer. Clin Transl Med 11(12):e595

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dou R et al (2021) EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer. Clin Transl Med 11(12):e595

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan L, Yang W, Feng W, Cao L, Wang X, Niu L, Li Y, Zhou W, Zhang Y, Liu J, Zhang H (2020) Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer. Ther Adv Med Oncol 12:1758835920947342

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Mahdy HA et al (2020) Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein. Life Sci 262:118518

Article  CAS  PubMed  Google Scholar 

Elrebehy MA et al (2022) miRNAs as cornerstones in colorectal cancerpathogenesis and resistance to therapy: a spotlight on signaling pathways interplay—a review. Int J Biol Macromol 214:583–600

Article  CAS  PubMed  Google Scholar 

Elshimy R et al (2017) MiR-133a and MiR-155 as potential minimally invasive biomarkers in breast cancer. Cancer Biol 7(1):96–105

Google Scholar 

Eslamizadeh S et al (2018) The role of microRNA signature as diagnostic biomarkers in different clinical stages of colorectal cancer. Cell J (Yakhteh) 20(2):220

Google Scholar 

Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269

Article  CAS  PubMed  Google Scholar 

Fadakar P et al (2016) Evaluation of SD-208, a TGF-Î2-RI kinase inhibitor, as an anticancer agent in retinoblastoma. Acta Med Iran 54(6):352–358

PubMed  Google Scholar 

Fearnhead NS, Wilding JL, Winney B, Tonks S, Bartlett S, Bicknell DC, Tomlinson IP, Mortensen NJM, Bodmer WF (2004) Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci 101(45):15992–15997

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fidler MM et al (2017) Assessing global transitions in human development and colorectal cancerincidence. Int J Cancer 140(12):2709–2715

Article  CAS  PubMed  Google Scholar 

Flatmark K, Høye E, Fromm B (2016) microRNAs as cancer biomarkers. Scand J Clin Lab Invest 76(sup245):S80–S83

Article  CAS  Google Scholar 

Guo Y et al (2021) Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis. Mol Cancer 20(1):93

Article  CAS  PubMed  PubMed Central